This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Formulation uses the company’s patented, high-bioavailability Liquid Structure CBD.
Ananda Scientific, a clinical-stage biotech company pioneering patented delivery technologies for cannabinoids, has developed a water-stable formulation using the company’s patented, high-bioavailability Liquid Structure CBD.
“Ananda’s innovative patented delivery technology (United States Patents 7,182,950 and 10.149,824) presents tremendous new opportunity for worldwide expansion of the CBD beverage sector,” said Mark J. Rosenfeld, Ananda Scientific CEO and Chief Science Officer. “We are excited to be paving the way through sound science with the first high-bioavailability cannabinoid formulation that stays in solution and otherwise remains stable at all ends of the supply chain.”